Literature DB >> 7535073

Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).

M Ono1.   

Abstract

Lenograstim, glycosylated recombinant human granulocyte colony stimulating factor (rHuG-CSF), is a glycoprotein that contains 4% O-glycosides with an approximate molecular weight of 20 kDa. The carbohydrate chain contributes to stabilisation of the protein by its ability to suppress polymerisation due to pH changes and to prevent denaturation at elevated temperatures. The carbohydrate chain also has an important role in maintaining biological stability in normal human serum. Furthermore, it is shown that glycosylated rHuG-CSF is more stable and resistant to degradation than non-glycosylated rG-CSF in vitro. In addition, we show the remarkable effects of combined therapy of lenograstim with an antibiotic in severe neutropenic infection models. These data demonstrate the possibility that such combination therapy may be applied to neutropenic patients with serious infections and that there is increased efficacy of antibiotic treatment when administered concurrently with lenograstim.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535073

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

Review 1.  Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

Review 2.  Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 3.  Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

4.  Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.

Authors:  L Rotondaro; E De Paolis; D Ferrero; L D'Alatri; G Raucci; A Fabbri; G J Gerwig; J P Kamerling; M F Mariani; A Mele; R De Santis
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

Review 5.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.